Exelixis (EXEL) Long-Term Investments (2010 - 2026)
Exelixis' Long-Term Investments was $544.93 million in Q2 2027, down 8.4% from $594.65 million a year earlier and down 16.1% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Long-Term Investments (2010 - 2026) Analysis & Trends
At the end of FY2026, Long-Term Investments at Exelixis came in at $603.6 million, down 5.3% from FY2025.
- Long-Term Investments shows a five-year compound annual growth rate of 10.2% (FY2021 to FY2026).
- In earlier years, Long-Term Investments was $637.29 million in FY2025, $728.72 million in FY2023 (-3.7%) and $756.73 million in FY2022 (+103.9%).
- The Q2 2027 figure marks the lowest quarterly Long-Term Investments since Q3 2025.
- Compared with a year earlier, Long-Term Investments was higher in three of the last six quarters, with growth averaging 6.3%.
- Per Business Quant data, EXEL's Long-Term Investments in the three quarters before Q2 2027 was $649.14 million (Q1 2027), $603.6 million (Q4 2026) and $578.29 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Exelixis | 14.42 Bn | 10.76 Bn | 608.03 Mn | 544.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 544.93 Mn |
| Apr 3, 2026 | 649.14 Mn |
| Jan 2, 2026 | 603.60 Mn |
| Oct 3, 2025 | 578.29 Mn |
| Jul 4, 2025 | 594.65 Mn |
| Apr 4, 2025 | 619.44 Mn |
| Jan 3, 2025 | 637.29 Mn |
| Sep 27, 2024 | 523.42 Mn |
| Jun 28, 2024 | 432.31 Mn |
| Mar 29, 2024 | 629.56 Mn |
| Dec 29, 2023 | 728.72 Mn |
| Sep 29, 2023 | 811.68 Mn |
| Jun 30, 2023 | 838.62 Mn |
| Mar 31, 2023 | 806.62 Mn |
| Dec 30, 2022 | 756.73 Mn |
| Sep 30, 2022 | 551.74 Mn |
| Jul 1, 2022 | 463.89 Mn |
| Apr 1, 2022 | 404.54 Mn |
| Dec 31, 2021 | 371.11 Mn |
| Oct 1, 2021 | 362.22 Mn |
API Access
Exelixis Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();